Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vickers

Showing results (411-420 of 835) with videos related to

Pageof 84
Sort By:
European Urology Oncology|February 20, 2021
How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?Andrew J Vickers, Giorgio Russo, Hans Lilja, et al.
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|March 2, 2013
Responses to the Acupuncture Trialists' Collaboration individual patient data meta-analysisAndrew J Vickers, Alexandra C Maschino, George Lewith, et al.
Urology|September 7, 2025
Guidelines for Meta-Analyses and Systematic Reviews in UrologyAndrew J Vickers, Melissa Assel, Rodney L Dunn, et al.
The Journal of Urology|August 11, 2025
Guidelines for Meta-Analyses and Systematic Reviews in UrologyAndrew J Vickers, Melissa Assel, Rodney L Dunn, et al.
The Journal of Urology|December 27, 2023
Adding a Coefficient for Race to the 4Kscore Improves Calibration for Black MenHelen Y Hougen, Daniel D Sjoberg, Jamie Thomas, et al.
The Journal of Urology|November 20, 2020
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?T Stonier, A L Tin, D D Sjoberg, et al.
Clinical Genitourinary Cancer|June 16, 2019
Can We Improve the Preoperative Prediction of Prostate Cancer Recurrence With Multiparametric MRI?Paolo Capogrosso, Emily A Vertosick, Nicole E Benfante, et al.
European Urology|March 10, 2018
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy MenDaniel D Sjoberg, Andrew J Vickers, Melissa Assel, et al.
Clinical Trials (London, England)|October 16, 2024
Successful completion of large, low-cost randomized cancer trials at an academic cancer centerAndrew J Vickers, Behfar Ehdaie, Hanae K Tokita, et al.
Health and Quality of Life Outcomes|August 7, 2010
Validation study of a web-based assessment of functional recovery after radical prostatectomyAndrew J Vickers, Caroline J Savage, Marwan Shouery, et al.
Pageof 84

Showing results (411-420 of 835) with videos related to

Sort By:
Pageof 84
European Urology Oncology|February 20, 2021
How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?Andrew J Vickers, Giorgio Russo, Hans Lilja, et al.
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|March 2, 2013
Responses to the Acupuncture Trialists' Collaboration individual patient data meta-analysisAndrew J Vickers, Alexandra C Maschino, George Lewith, et al.
Urology|September 7, 2025
Guidelines for Meta-Analyses and Systematic Reviews in UrologyAndrew J Vickers, Melissa Assel, Rodney L Dunn, et al.
The Journal of Urology|August 11, 2025
Guidelines for Meta-Analyses and Systematic Reviews in UrologyAndrew J Vickers, Melissa Assel, Rodney L Dunn, et al.
The Journal of Urology|December 27, 2023
Adding a Coefficient for Race to the 4Kscore Improves Calibration for Black MenHelen Y Hougen, Daniel D Sjoberg, Jamie Thomas, et al.
The Journal of Urology|November 20, 2020
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?T Stonier, A L Tin, D D Sjoberg, et al.
Clinical Genitourinary Cancer|June 16, 2019
Can We Improve the Preoperative Prediction of Prostate Cancer Recurrence With Multiparametric MRI?Paolo Capogrosso, Emily A Vertosick, Nicole E Benfante, et al.
European Urology|March 10, 2018
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy MenDaniel D Sjoberg, Andrew J Vickers, Melissa Assel, et al.
Clinical Trials (London, England)|October 16, 2024
Successful completion of large, low-cost randomized cancer trials at an academic cancer centerAndrew J Vickers, Behfar Ehdaie, Hanae K Tokita, et al.
Health and Quality of Life Outcomes|August 7, 2010
Validation study of a web-based assessment of functional recovery after radical prostatectomyAndrew J Vickers, Caroline J Savage, Marwan Shouery, et al.
Pageof 84